Literature DB >> 20583827

Potential implications for monitoring serum bile acid profiles in circulation with serum proteome for carbon tetrachloride-induced liver injury/regeneration model in mice.

Takashi Shimada1, Tsuyoshi Nakanishi, Atsuhiko Toyama, Satoshi Yamauchi, Atsuhiro Kanzaki, Hideshi Fujiwake, Taka-Aki Sato, Masaya Ikegawa.   

Abstract

Bile acids have recently emerged as versatile signaling molecules, and their signaling pathway is a promising target for the treatment of metabolic diseases. Here, we developed a highly sensitive and high-throughput quantification method for six taurine- and glycine-conjugated bile acids using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry after solid-phase extraction (SPE-MALDI-TOF MS). In a carbon tetrachloride (CCl4)-induced liver injury/regeneration model in mice, serum bile acid profiles were monitored, and the same samples were separated by two-dimensional polyacrylamide gel electrophoresis (2-D PAGE), and protein spots that significantly changed in quantity in a serial time points were identified by MALDI-TOF MS. Serum taurocholic acid (TCA) concentration was significantly elevated earlier than the increase of serum aspartate aminotransferase (AST)/alanine aminotransferase (ALT) activity, a potentially sensitive marker for minimal hepatic damage. Furthermore, TCA peaked at 20 h after treatment when massive serum proteins appeared in circulation. It should be noted that direct MALDI-imaging mass spectrometry (IMS) has succeeded in showing a hepatic lobular distribution change of TCA, predominantly seen in zone 1 area whereas necrotic changes were dominant in zone 3 area. The in-depth analysis of bile acid profiles in circulation with hepatic lobular distribution is a strong basis to understand the serum proteome in CCl4-induced liver injury model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583827     DOI: 10.1021/pr1002388

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Serum proteomic profiling in patients with drug-induced liver injury.

Authors:  L N Bell; R Vuppalanchi; P B Watkins; H L Bonkovsky; J Serrano; R J Fontana; M Wang; J Rochon; N Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2012-03       Impact factor: 8.171

Review 2.  Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics.

Authors:  David E Amacher; Shelli J Schomaker; Jiri Aubrecht
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

3.  Genomics and proteomics in liver fibrosis and cirrhosis.

Authors:  Rebekka A Hannivoort; Virginia Hernandez-Gea; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2012-01-03

4.  Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARα(PAC) mice due to dysregulated bile acid synthesis.

Authors:  Hui-Xin Liu; Ying Hu; Samuel W French; Frank J Gonzalez; Yu-Jui Yvonne Wan
Journal:  Oncotarget       Date:  2015

5.  Chronological Profiling of Plasma Native Peptides after Hepatectomy in Pigs: Toward the Discovery of Human Biomarkers for Liver Regeneration.

Authors:  Kohta Iguchi; Etsuro Hatano; Takashi Nirasawa; Noriyuki Iwasaki; Motohiko Sato; Gen Yamamoto; Kenya Yamanaka; Tatsuya Okamoto; Yosuke Kasai; Naohiko Nakamura; Hiroaki Fuji; Tomohito Sakai; Nobuto Kakuda; Satoru Seo; Kojiro Taura; Kei Tashiro; Shinji Uemoto; Masaya Ikegawa
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

6.  Effects of Liver Fibrosis Progression on Tissue Relaxation Times in Different Mouse Models Assessed by Ultrahigh Field Magnetic Resonance Imaging.

Authors:  Andreas Müller; Katrin Hochrath; Jonas Stroeder; Kanishka Hittatiya; Günther Schneider; Frank Lammert; Arno Buecker; Peter Fries
Journal:  Biomed Res Int       Date:  2017-01-18       Impact factor: 3.411

7.  Comparative metabolome analysis of serum changes in sheep under overgrazing or light grazing conditions.

Authors:  Jize Zhang; Yang Gao; Huiqin Guo; Yong Ding; Weibo Ren
Journal:  BMC Vet Res       Date:  2019-12-26       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.